AzTrials
AzTrials

BurnoutNCT07437443

Burnout, Secondary Traumatic Stress and Inflammatory Biomarkers in ICU Healthcare Workers

An observational study of Burnout and Secondary Traumatic Stress, run by Elazıg Fethi Sekin Sehir Hastanesi at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Healthcare professionals working in intensive care units (ICUs) are frequently exposed to high levels of psychological stress due to critically ill patients, frequent encounters with death, complex clinical decision-making, and prolonged working hours. Read more about this study

Who is it for?
Any age
What is being tested?
Psychometric Assessment and Blood Sampling
How many people
140 participants
Where
1 siteTurkey (Türkiye)
Study dates
23 Feb 2026to 10 Mar 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: The study population consists of healthcare professionals working in intensive care units (anesthesia, internal medicine, and chest diseases ICUs) at Elazığ Fethi Sekin City Hospital. Participants include physicians, nurses, anesthesia technicians, and other healthcare staff who are actively involved in the care of critically ill patients. All participants are adults undergoing routine annual occupational health screening and voluntarily agree to participate in the study.

Who may be able to join

  • Age ≥18 years
  • Active employment in an intensive care unit (anesthesia, internal medicine, or chest diseases ICU)
  • Participation in routine annual occupational health screening
  • Willingness to provide additional blood sample for research purposes
  • Voluntary participation with written informed consent

Who cannot join

  • Active infection at the time of assessment
  • Use of systemic steroids, immunosuppressive agents, or chemotherapy within the last 4 weeks
  • Known autoimmune or rheumatologic disease
  • Hematologic malignancy or severe hematologic disorder
  • Pregnancy
  • Refusal to provide additional blood sample
  • Incomplete questionnaire data

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Fethi Sekin City Hospital

    Elâzığ, Elâzığ, 23100

Other trials in Turkey (Türkiye)

About this study

Official title: Relationship Between Burnout, Secondary Traumatic Stress, and Inflammatory Biomarkers in Intensive Care Unit Healthcare Workers

Healthcare professionals working in intensive care units (ICUs) are frequently exposed to high levels of psychological stress due to critically ill patients, frequent encounters with death, complex clinical decision-making, and prolonged working hours. This environment increases the risk of burnout and secondary traumatic stress, which may not only affect mental well-being but also have measurable physiological consequences.

Emerging evidence suggests that chronic psychological stress and burnout may influence immune function through activation of proinflammatory pathways. Elevated levels of inflammatory biomarkers such as C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and neutrophil-to-lymphocyte ratio (NLR) have been associated with stress-related conditions. However, data examining the relationship between burnout, secondary traumatic stress, and inflammatory biomarkers in intensive care healthcare workers remain limited.

This cross-sectional observational study aims to investigate the association between burnout and secondary traumatic stress levels, assessed using validated psychometric instruments (Maslach Burnout Inventory and Professional Quality of Life Scale), and inflammatory biomarkers (CRP, IL-6, TNF-α, and NLR) in ICU healthcare workers. Blood samples will be obtained in conjunction with routine annual health screening, and additional serum samples will be collected for biomarker analysis. The study seeks to clarify the psychoneuroimmunological mechanisms underlying occupational stress in critical care settings.

Being tested
Psychometric Assessment and Blood Sampling
Keywords
Burnout, Secondary Traumatic Stress, Intensive Care Unit, Healthcare Workers, Interleukin-6, TNF-alpha
Medical subject headings
Burnout, Psychological, Compassion Fatigue, Occupational Stress, Inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Psychometric Assessment and Blood SamplingOther

    Administration of validated burnout and secondary traumatic stress questionnaires and collection of blood samples for inflammatory biomarker analysis. No therapeutic or clinical intervention is performed.

Study groups in NCT07437443
Study groupRoleWhat they receive
ICU Healthcare WorkersHealthcare professionals aged 18 years and older working in intensive care units (anesthesia, internal medicine, and chest diseases ICUs) who voluntarily participate in the study. Participants will complete validated psychometric scales assessing burnout and secondary traumatic stress, and blood samples will be collected for inflammatory biomarker analysis.
Receives: Other: Psychometric Assessment and Blood Sampling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Association Between Burnout Levels and Inflammatory Biomarkers

    Evaluation of the relationship between Maslach Burnout Inventory (MBI-HSS) total and subscale scores and inflammatory biomarker levels (CRP, IL-6, TNF-α, and NLR) using correlation and multivariable linear regression analysis.

    Measured: At the time of assessment (single time point)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2026
  2. Study start23 Feb 2026
  3. Primary completion1 Mar 2026
  4. Study completion10 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
140 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07437443
Sponsor's protocol ID
EFSH-ICU-STRESS-2026-22-35
Status last verified
Apr 2026
First submitted
22 Feb 2026
Last updated
23 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Burnout and Secondary Traumatic Stress, run by Elazıg Fethi Sekin Sehir Hastanesi at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Association Between Burnout Levels and Inflammatory Biomarkers (time frame: At the time of assessment (single time point)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in